Debanjan Ray

Chief Financial Officer and Head of Corporate Development @ CytomX Therapeutics

Found 2 valid emails:

CytomX Therapeutics

United States
51 - 200 employees
CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.

SalesQL reveals any person's emails directly from Google Chrome: